CervoMed Inc. (CRVO)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-05-18) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-03-17) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2025-11-10) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-08-11) · 99.1 | ||
| 10-Q | Q2-2025 | — | ||
| 10-Q | Q1-2025 | 8-K (2025-05-12) · 99.1 | 8-K (2025-03-18) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2024-11-13) · 99.1 · 99.2 · 99.3 | ||
| 10-Q | Q3-2024 | 8-K (2024-08-15) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-05-15) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-04-05) · 99.1 | ||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | 8-K (2023-11-13) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Condensed Consolidated Balance Sheets | — |
|
| Condensed Consolidated Balance Sheets (current Period Unaudited) | — |
|
| Condensed Consolidated Balance Sheets (current Period Unaudited) (P) | — |
|
| Condensed Consolidated Balance Sheets (P) | — |
|
| Condensed Consolidated Statements of Operations and Comprehensive (loss) Income (unaudited) | — |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Changes In Convertible Preferred Stoc and Stockholders' Equity (deficit) (unaudited) | — |
|
| Condensed Consolidated Statements of Changes In Convertible Preferred Stock and Stockholders' Deficit (unaudited) | — |
|
| Consolidated Statements of Changes In Convertible Preferred Stock and Stockholders' Equity (deficit) | ||
| Consolidated Statements of Stockholders' Equity (unaudited) | — |
|
| Condensed Consolidated Statements of Cash Flows | ||
| Notes | ||
| Award Timing Disclosure | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Note 1 | ||
| Note 1 - The Company and Description of Business | — |
|
| Note 10 | ||
| Note 10 - Stock-based Compensation Stock | — |
|
| Note 11 | ||
| Note 11 - Segments | — |
|
| Note 12 | ||
| Note 12 - Subsequent Events | — |
|
| Note 13 | ||
| Note 14 | ||
| Note 2 | ||
| Note 2 - Liquidity and Capital Resources | — |
|
| Note 3 | ||
| Note 3 - Summary of Significant Accounting Policies | — |
|
| Note 4 | ||
| Note 4 - Fair Value of Financial Instruments | — |
|
| Note 5 | ||
| Note 5 - Significant Agreements and Contracts | — |
|
| Note 6 | ||
| Note 6 - Prepaid Expenses | — |
|
| Note 7 | ||
| Note 7 - Accrued Expenses and Other Current Liabilities | — |
|
| Note 8 | ||
| Note 8 - Commitments and Contingencies | — |
|
| Note 9 | ||
| Note 9 - Stockholders' Equity and Common Stock Warrants | — |
|